Victory Capital Management
MBIO icon

Victory Capital Management’s Mustang Bio MBIO Stock Holding History

Victory Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13
Closed -$28K – 2940
2020
Q1 		$28K Buy
+13
New +$33.3K ﹤0.01% 2978
2019
Q4 		– Sell
-7
Closed -$17K – 2993
2019
Q3 		$17K Buy
+7
New +$19.1K ﹤0.01% 3099

Other funds holding MBIO

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Victory Capital Management's MBIO Position: Q2 2020 in Review

Victory Capital Management sold out of Mustang Bio (MBIO) in Q2 2020, closing a stake of 13 shares — an estimated $28K sold.

Victory Capital Management first reported a position in MBIO in Q3 2019 and held it in 2 quarters. The position peaked at $28K in Q1 2020. 73 funds tracked by Wall St. Rank hold MBIO as of Q2 2020.

  • Victory Capital Management reported no remaining Mustang Bio position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 13 Mustang Bio shares in Q2 2020, an estimated $28K.
  • Victory Capital Management first reported a position in Mustang Bio in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Mustang Bio position peaked at $28K in Q1 2020.
  • 73 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.